Edition:
United States

MDxHealth SA (MDXH.BR)

MDXH.BR on Brussels Stock Exchange

3.39EUR
16 Feb 2018
Change (% chg)

€0.00 (+0.15%)
Prev Close
€3.39
Open
€3.40
Day's High
€3.43
Day's Low
€3.39
Volume
73,394
Avg. Vol
218,119
52-wk High
€5.78
52-wk Low
€2.89

Chart for

About

MDxHealth SA is a Belgium-based multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis... (more)

Overall

Beta: 1.11
Market Cap(Mil.): €169.58
Shares Outstanding(Mil.): 49.95
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

BRIEF-MDxHealth ‍Develops Blood Test For Prostate Cancer Patients​

* ‍DEVELOPS BLOOD TEST TO GUIDE PRECISION-TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER PATIENTS​

Jan 18 2018

BRIEF- MDxHealth Lowers Guidance For 2017

* HAS FACED TIMING ISSUES IN OBTAINING BILLABLE CASES FROM CONTRACTED CONFIRMMDX CUSTOMERS AND FROM POST-MARKETING STUDIES

Dec 28 2017

BRIEF-MDxHealth teams up with Ferrer for distribution of its prostate cancer test SelectMDx in Spain

* REG-MDXHEALTH TEAMS UP WITH PHARMACEUTICAL COMPANY FERRER FOR DISTRIBUTION OF ITS PROSTATE CANCER TEST SELECTMDX IN SPAIN

Nov 20 2017

BRIEF-MDX Pcl posts ‍qtrly net profit of 86.1 mln baht

* ‍Qtrly net profit 86.1 million baht versus 19.8 million baht Source text for Eikon: Further company coverage:

Nov 14 2017

BRIEF-MDxHealth 9M total revenue at 30.5 million dollars

* 9M (NOT Q3) NET LOSS $‍​7.4 MILLION VERSUS LOSS OF $10.3 MILLION YEAR AGO

Nov 02 2017

BRIEF-MDxhealth enters distribution agreement with Unilabs for SelectMDx

* ‍MDXHEALTH ENTERS INTO DISTRIBUTION AGREEMENT WITH UNILABS FOR SELECTMDX FOR PROSTATE CANCER ​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Oct 30 2017

BRIEF-MDxHealth opens new laboratory in the Netherlands

* MDXHEALTH OPENS NEW SERVICE AND RESEARCH LABORATORY IN THE NETHERLANDS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Oct 05 2017

BRIEF-MDxHealth appoints Michael K. Brawer as Chief Medical Officer‍​

* ANNOUNCES APPOINTMENT OF MICHAEL K. BRAWER, MD AS CHIEF MEDICAL OFFICER‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 06 2017

BRIEF-MDxHealth H1 EBITDA rises to 1.4 million dollars

* H1 ‍TOTAL REVENUE OF $24.3 MILLION, UP 87% FROM $12.9 MILLION IN 2016​

Aug 31 2017

Earnings vs. Estimates